ClinicalTrials.gg
RecruitingNCT06296433XR-PAINUpdated May 10, 2024

Extended Reality-Assisted Therapy for Chronic Pain Management

An interventional study of VR rehabilitation and VR video application in Chronic Pain and Low Back Pain, sponsored by Institut d'Investigacions Biomèdiques August Pi i Sunyer. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-05-10.

Sponsored by Institut d'Investigacions Biomèdiques August Pi i Sunyer · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 174 studies in Chronic Pain with a site in Spain — 34 open to participants now, 40 under way, 1 of them phase 3. Chronic Pain · Spain.

Planned enrollment
40th of 141
100 · median 66
Started
2024
with 11 others
No phase
126 of 174
23 open now
Primary completion
2024-11
later than 9 of 39 live
Registered
131st of 174
by date

Among the 174 studies in Chronic Pain with a site in Spain, this one is the 40th largest by planned enrollment of the 141 interventional ones that give a count, is one of 12 that started in 2024, is one of 126 with no phase, reaches primary completion later than 9 of the 39 other live ones, and was the 131st registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

34 of the 174 studies in Chronic Pain with a site in Spain are open now. Recruiting first, the newest first:

28 more — sign in →

All 34 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 174 studies in Chronic Pain with a site in Spain, or all of them as a file.
02

Study summary

The goal of this clinical trial is to test a home-based virtual reality rehabilitation application in patients with chronic low back pain. The main question it aims to answer are:

Is a prototype of a novel VR software application effective at reducing pain, improving daily function, improving range of motion, and reducing fear of movement in adult patients with chronic low back pain compared with a passive VR intervention? Participants in the treatment group will use the application daily for 20 minutes for a period of 3 weeks at home and unsupervised. Researchers will compare use of the VR application with a control group that watches 2D video to see if the treatment group have improved pain, disability, range of motion, and fear of movement.

Read the detailed description

This is a two-arm randomized parallel controlled trial designed to test a prototype of a VR software application that the investigators have developed for patients with chronic low back pain. The app contains (1) educational messages delivered by a virtual therapist, (2) gamified exercises in which the patient has to move to reach goals or avoid objects, (3) therapeutic exercises, in which patients perform difficult or feared movements, (4) relaxation/mindfulness. There will be two groups consisting of adult patients of both sexes with persistent low back pain. Patients (n = 100) will be randomly assigned to either an interventional VR treatment (n = 50) or a control treatment (n = 50).

Patients in the VR intervention group will use the VR software application daily for a 20-minute training program. In the virtual reality application, they will be embodied into an avatar through congruent visuotactile and visuomotor stimulation (observed in first person) and will perform gamified movements and exercises for 15-20 minutes. These exercises will increase in difficulty for 3 weeks and will include educational and relaxation components. The control treatment will consist of a passive VR intervention in which the patient watches a TV show on a 2D screen but while wearing the virtual reality headset. They will be able to choose from three popular TV series with short episodes (20 minutes). The investigators will use validated outcome measures to assess changes in pain and function. These will be measured at baseline, after treatment (3 weeks), and at 1 month follow-up for both the treatment group and the control group. Both groups will be advised to continue their normal daily activities and routines, with no restrictions on activity or exercise, in addition to VR treatment.

03

Conditions studied

  • Chronic Pain
  • Low Back Pain

Keywords

  • virtual reality
  • embodiment
  • chronic pain
  • rehabilitation
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-65 of either sex
  • Diagnosis of chronic low back pain of >12 weeks, with or without associated somatic referred leg pain
  • Average pain intensity over the previous month ≤7/10 and ≥ 2/10)

Exclusion criteria

Exclusion Criteria:

  • Spondylolysis, fracture, cauda equina syndrome, active spinal infection
  • Acute radiculopathy or compromised nerve root
  • Recent spinal surgery (\<12 months) or lower limb surgery (\<3 months)
  • Major depressive symptoms as indicated by the Patient Health Questionnaire-2 depression screen score of 4 or more.
  • Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, balance disorder, or other neurological diseases that may prevent the use of virtual reality or adverse effects.
  • Cardiopulmonary or pulmonary disorder with to physical exercise
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    VR rehabilitation treatment

    Daily use of VR rehabilitation program independently at home for a period of 3 weeks. Each daily session is 20 minutes.

    Other: VR rehabilitation

  • Placebo comparator
    VR control treatment

    Daily watching 2D video independently at home using VR headset for a period of 20 minutes.

    Other: VR video application

Interventions

  • OtherVR rehabilitation

    VR software application containing education, exergames, therapeutic exercises and relaxation sections.

  • OtherVR video application

    VR software application that plays 2D nature videos

06

What researchers measure

Primary outcomes

  1. Brief Pain Inventory

    Allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. Minimum score 0, maximum score 70, higher score = worse outcome.

    Time frame: Baseline, 4 weeks, 8 weeks

Secondary outcomes

  1. Roland-Morris Disability Questionnaire

    The Roland-Morris Disability Questionnaire is a self-reported measure consisting of 24 yes/no questions designed to assess functional disability related to back pain, with higher scores indicating greater disability. Minimum score 0, maximum score 24.

    Time frame: Baseline, 4 weeks, 8 weeks

  2. Short-Form 12

    The Short-Form-12 is a widely used, short-form health survey consisting of 12 questions that assess physical and mental health functioning, providing a concise measure of overall health status. Scores above 50 represent better than average quality of life, below 50 represents worse than average quality of life.

    Time frame: Baseline, 4 weeks, 8 weeks

  3. Patient Global Impression of Change

    The Patient Global Impression of Change is a self-reported assessment used to measure an individual's perceived change in health status or symptoms over time, typically ranging from "very much worse" to "very much improved." Minimum score 1, maximum score 7. Higher score indicated greater improvement in patient's condition (better outcome)

    Time frame: Baseline, 4 weeks, 8 weeks

  4. Pain Catastrophization Scale

    a self-report measure consisting of two subscales, assessing beliefs about how physical activity and work-related activities may exacerbate pain and lead to avoidance behaviors in individuals with low back pain. Minimum score 0, maximum score 52. Higher score indicates worse outcome.

    Time frame: Baseline, 4 weeks, 8 weeks

Other outcomes

  1. Spinal Range of motion

    Video analysis will be used to measure spinal range of motion for flexion, extension and side flexion.

    Time frame: Baseline, 4 weeks, 8 weeks

  2. Adherence to treatment

    Measured automatically in the VR headset

    Time frame: 4 weeks

  3. Embodiment

    Self report questionnaire

    Time frame: 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Study data will be made available on request from the study authors

Supporting information: Clinical study report

Time frame: No time limit. Data will be made available on completion of the trial.

Access criteria: Email request directly from Principle Investigator, Prof. Maria Sanchez-Vives (msanche3@recerca.clinic.cat)

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Nov 2024, 7 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 7 months is below that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 29, 2024
First posted
Mar 6, 2024
StartActual
Apr 1, 2024
Primary completionEst.
Nov 30, 2024
CompletionEst.
Dec 31, 2024
Last update
May 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06296433
Lead sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Responsible party
Prof. Maria V. Sanchez-Vives (Professor, Institut d'Investigacions Biomèdiques August Pi i Sunyer) — Principal investigator
First posted
Mar 6, 2024
Start date
Apr 1, 2024
Primary completion
Nov 30, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
May 10, 2024

Study contacts

Tony Donegan
Contact
tonydonegan@gmail.com
+34676606825
Maria V Sanchez-Vives
principal investigator · Institut d'Investigacions Biomèdiques August Pi i Sunyer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion